New National Polling Shows Strong Support for Prevention-Focused Dental Hygiene Care While Gaps in Access to Care Persist
Ottawa, Ontario--(Newsfile Corp. - February 26, 2026) - New national public opinion research released today by the Canadian Dental Hygienists Association (CDHA) shows Canadians place exceptionally high trust in dental hygienists and strongly support prevention-focused dental hygiene care, while also acknowledging that barriers to access remain. The polling, conducted by Abacus Data, found that 96 per cent of Canadians hold a positive impression of dental hygienists, with more than eight in te
Healthcare and Hospitals, Health
2026-02-26 9:40 AM EST | Canadian Dental Hygienists Association
Un nouveau sondage national montre un soutien massif aux soins d'hygiène dentaire axés sur la prévention tandis que des obstacles à l'accès aux soins persistent
Ottawa, Ontario--(Newsfile Corp. - 26 février 2026) - Une nouvelle recherche sur l'opinion publique nationale publiée aujourd'hui par l'Association canadienne des hygiénistes dentaires (ACHD) indique que les Canadiennes et Canadiens accordent une confiance exceptionnellement élevée aux hygiénistes dentaires et sont très favorables aux soins d'hygiène dentaire axés sur la prévention tout en reconnaissant la persistance d'obstacles à l'accè
Healthcare and Hospitals, Health
2026-02-26 9:40 AM EST | Canadian Dental Hygienists Association
OTF + Lilly Collaboration Update on Registration Response | OMA QI Scaling Initiative Gains National Response, Bringing Together Diverse Practice Types Across 39 States
Denver, Colorado--(Newsfile Corp. - February 26, 2026) - The Obesity Medicine Association (OMA) is seeing strong early momentum for its Implementation into Practice Collaborative (IPC), a program designed to help clinicians strengthen obesity care through practical, evidence-based improvements in outpatient settings. The IPC is part of a multi-phase Quality Improvement (QI) initiative created specifically for OMA members. It was developed in collaboration with the Obesity Treatment Foun
Healthcare and Hospitals, Health
2026-02-26 8:00 AM EST | Obesity Medicine Association
LevelJump Announces Grant of Stock Options
Toronto, Ontario--(Newsfile Corp. - February 26, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("Leveljump" or the "Company") announces that, pursuant to the Company's 2022 Equity Incentive Plan, it has granted an aggregate of 2,250,000 incentive stock options (the "Options") to three directors of the Company. Each Option entitles the optionee to acquire one common share of the Company at an exercise price of $0.065 per common share until February 24, 2031. There are no vesting restrictions
Healthcare and Hospitals, Health
2026-02-26 8:00 AM EST | LevelJump Healthcare Corp.
Aleen Inc. Announces Its Listing on the Frankfurt Stock Exchange
Toronto, Ontario--(Newsfile Corp. - February 26, 2026) - Aleen Inc. (CSE: ALEN.U), a digital wellness company, is pleased to announce that its shares have officially commenced trading on the Frankfurt Stock Exchange (XFRA) since February 25, 2026. The listing marks a significant milestone in Aleen Inc.'s global growth strategy and strengthens the Company's presence in the European capital markets. By joining one of the world's leading financial exchanges, Aleen Inc. expands access to in
2026-02-26 8:00 AM EST | Aleen Inc.
Rock Salt Marketing Ranked Among Best SEO Agencies in the USA on DesignRush
Salt Lake City, Utah--(Newsfile Corp. - February 26, 2026) - Rock Salt Marketing Cooperative has been named one of the Best SEO Agencies in the USA by DesignRush, following the platform's latest review of search engine optimization firms across the country.
Real Estate, Travel, Health, Legal
2026-02-26 7:45 AM EST | Rock Salt Marketing Cooperative
TempraMed Reports over 275 Clinicians Recommending VIVI Cap to Patients on Leading FrontrowMD Platform Across the United States
Vancouver, British Columbia--(Newsfile Corp. - February 26, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce that more than 275 physicians across the United States have recommended and included VIVI Cap in the offers available to their patients across FrontrowMD, a leading physician engagement and education platform.
Technology, Biotechnology, Pharmaceuticals, Health
2026-02-26 7:00 AM EST | TempraMed Technologies Ltd.
Optimi Health Reports Early Clinical Rollout of Natural Psilocybin Capsules for Treatment-Resistant Depression in Australia
Vancouver, British Columbia--(Newsfile Corp. - February 26, 2026) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-licensed manufacturer of pharmaceutical-grade psychedelic drug products, today reported that patients diagnosed with treatment-resistant depression (TRD) have now been treated in Australia using the Company's naturally derived 5 mg psilocybin capsules under the Authorised Prescriber Scheme. The clinical a
Biotechnology, Pharmaceuticals, Health, Psychedelics
2026-02-26 7:00 AM EST | Optimi Health Corp.
Optimi Health berichtet über den frühen klinischen Einsatz natürlicher Psilocybin-Kapseln zur Behandlung therapieresistenter Depressionen in Australien
Vancouver, British Columbia--(Newsfile Corp. - Donnerstag, 26. Februar 2026) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" oder das "Unternehmen"), ein von Health Canada lizenzierter Hersteller pharmazeutischer Psychedelika-Produkte in pharmazeutischer Qualität, gab heute bekannt, dass in Australien nun Patienten mit therapieresistenter Depression (TRD) unter dem Authorised Prescriber Scheme mit den natürlich gewonnenen 5-mg-Psilocybin-Kapseln d
Biotechnology, Pharmaceuticals, Health, Psychedelics
2026-02-26 7:00 AM EST | Optimi Health Corp.
Izotropic's "Izotropic Africa" Enters Partnership Discussions with the Mohammed VI Foundation for Science & Health
Sacramento, California--(Newsfile Corp. - February 25, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces that, further to its February 18t
2026-02-25 8:00 AM EST | Izotropic Corporation
Aleen Inc. Advances Personal Account Infrastructure Following AI Agent Development
Toronto, Ontario--(Newsfile Corp. - February 25, 2026) - Aleen Inc. (CSE: ALEN.U), a digital wellness company, announces continued internal progress in strengthening its Personal Account infrastructure following the previously announced development of Wellness AI Agents. Building on its AI agent framework, Aleen Inc. is optimizing the integration of these assistive tools within the Personal Account environment. Current improvements focus on enhancing internal system performance, increas
2026-02-25 8:00 AM EST | Aleen Inc.
Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference
Toronto, Ontario--(Newsfile Corp. - February 25, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, is pleased to announce that it will participate at the upcoming TD Cowen 46th Annual Health Care Conference in Boston, MA. Members of management will present on March 4, 2026, at 10:30 a.m. EST.
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2026-02-25 7:27 AM EST | Cardiol Therapeutics Inc.
Scryb Reports Positive Q1 2026: Cash Increased 50%, Liabilities Down 27%, Remains Largest Shareholder of Cybeats
Toronto, Ontario--(Newsfile Corp. - February 25, 2026) - Scryb Inc. (CSE: SCYB) ("Scryb" or the "Company") announces that it has filed its audited consolidated financial statements and Management's Discussion and Analysis for the fiscal quarter ended December 31, 2025 ("Q1 2026"). The filings are available on SEDAR+. Q1 2026 Highlights Cash position improved by 50% to $1.2 million (from $0.8 million at September 30, 2025), with working capital rising 6
Biotechnology, Healthcare and Hospitals, Health
2026-02-25 7:01 AM EST | Scryb Inc.
PreveCeutical Announces Canadian Patent Office Allowance of Innovative Pain Therapy Technology
Vancouver, British Columbia--(Newsfile Corp. - February 25, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is pleased to announce that the Canadian Patent Office has allowed Canadian Patent Application No. 3127020, titled "A Cyclic Peptide", which relates to the Company's pain therapy program. This allowance represents a significant milestone in the protection of PreveCeutical's proprietary technologies aime
Biotechnology, Pharmaceuticals, Health
2026-02-25 3:00 AM EST | PreveCeutical Medical Inc.
Adia Med of Winter Park Expands into Cosmetics Due to High Patient Demand - Now Interviewing Nurse Practitioners for Hair Growth and Aesthetic Procedures
Winter Park, Florida--(Newsfile Corp. - February 24, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and innovative wellness solutions through its subsidiary Adia Med, today announced that its Winter Park clinic is actively interviewing candidates for a Nurse Practitioner position specializing in cosmetic treatments, including advanced hair growth therapies.
Healthcare and Hospitals, Health
2026-02-24 8:30 AM EST | Adia Nutrition Inc.
Functional Brands Inc. (MEHA), Launches www.Tru2u.health, a Digital Health Platform Delivering Peptides, GLP-1 Based Care with Board-Certified Telehealth Support and Clean Supplements
Lake Oswego, Oregon--(Newsfile Corp. - February 24, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced the official launch of www.Tru2u.health, a digital health platform dedicated to helping individuals achieve their health goals through medication-based treatment, clean supplementation, and clinically guided wellness solutions. "Tru2u.health
Household / Consumer / Cosmetics, Health
2026-02-24 8:00 AM EST | Functional Brands Inc.
QScreen AI Advances Structured Commercial Discussions Following Canadian Trade Mission to Mexico
Toronto, Ontario--(Newsfile Corp. - February 23, 2026) - QScreen AI Inc (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP), an innovator fusing Quantum-AI technologies to transform health screening and employee wellness, today provided an update on its participation in the official Government of Canada Trade Mission to Mexico, reporting substantive commercialization discussions with senior institutional and enterprise stakeholders as part of its broader North American growth strategy. Building on
2026-02-23 7:00 AM EST | QScreen AI Inc.
Rapid Dose Therapeutics Advances Cannabinoid Research and Clinical Evaluation of QuickStrip(TM) Platform
Burlington, Ontario--(Newsfile Corp. - February 23, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology company focused on innovative drug delivery solutions, today provided an update on its ongoing cannabinoid research initiatives and clinical evaluation of its proprietary QuickStrip™ oral thin film delivery platform. Independent research led by colleagues Dr. Patrick Neary of the Faculty
2026-02-23 6:12 AM EST | Rapid Dose Therapeutics Corp.
DiagnosTear Advances UK Market Entry Through Commercial Collaboration with Hanson Medical
Vancouver, British Columbia--(Newsfile Corp. - February 20, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), a developer of rapid point-of-care diagnostics for ophthalmic conditions, today announced that it has entered into a Letter of Intent ("LOI") with Hanson Instruments Ltd. (trading as Hanson Medical), a United Kingdom-based supplier of ophthalmic and optometric equipment, to exclusively explore a commercial partnership for the TeaRx™ dr
2026-02-20 5:00 PM EST | DiagnosTear Technologies Inc.
Jones Healthcare Group Wins Best of Show and Best in Class Honours at PAC Global Awards for Qube(TM) Eco
London, Ontario--(Newsfile Corp. - February 20, 2026) - As healthcare systems face increasing pressure to reduce waste and carbon impact, packaging innovation must deliver measurable results without compromising patient safety or pharmacy workflow. At the same time, environmental claims across industries are under greater scrutiny, with regulators, retailers and consumers demanding proof over promise. At the 2026 PAC Global Awards ceremony, held February 18-19 in Toronto, Jones Healthca
Healthcare and Hospitals, Pharmaceuticals, Health
2026-02-20 12:36 PM EST | Jones Healthcare Group